PUBLISHER: Grand View Research | PRODUCT CODE: 1529619
PUBLISHER: Grand View Research | PRODUCT CODE: 1529619
Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 - 2030
Hydrogel-based Drug Delivery System Market Growth & Trends:
The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.
Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.
The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.
There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.
Hydrogel-based Drug Delivery System Market Report Highlights:
- Based on polymer origin, the synthetic segment held the largest proportion of market share in 2023
- The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology
- The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength
- Based on delivery route, the ocular segment accounted for the largest revenue share in 2023
- The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out
- North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems
- In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Hydrogel-based Drug Delivery System Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Billion)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Hydrogel-based Drug Delivery System Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Hydrogel-based Drug Delivery System Market: Polymer Origin Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Hydrogel-based Drug Delivery System Market: Polymer Origin Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Natural
- 4.3.1. Natural Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Synthetic
- 4.4.1. Synthetic Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Hybrid
- 4.5.1. Hybrid Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Hydrogel-based Drug Delivery System Market: Delivery Route Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Hydrogel-based Drug Delivery System Market: Delivery Route Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. Subcutaneous
- 5.3.1. Subcutaneous delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Ocular
- 5.4.1. Ocular delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Oral Cavity
- 5.5.1. Oral Cavity delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Topical
- 5.6.1. Topical delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Others
- 5.7.1. Other delivery routes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Hydrogel-based Drug Delivery System Market: Regional Estimates & Trend Analysis
- 6.1. Hydrogel-based Drug Delivery System Market Share, By Region, 2023 & 2030, USD Billion
- 6.2. North America
- 6.2.1. North America Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
- 6.2.2.1. U.S. Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
- 6.2.3.1. Canada Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Mexico
- 6.2.4.1. Mexico Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. UK
- 6.3.2.1. UK Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
- 6.3.3.1. Germany Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
- 6.3.4.1. France Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Italy
- 6.3.5.1. Italy Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Spain
- 6.3.6.1. Spain Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
- 6.3.7.1. Denmark Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
- 6.3.8.1. Sweden Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Norway
- 6.3.9.1. Norway Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. China
- 6.4.2.1. China Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Japan
- 6.4.3.1. Japan Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
- 6.4.4.1. India Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. South Korea
- 6.4.5.1. South Korea Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Brazil Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Argentina
- 6.5.3.1. Argentina Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. Saudi Arabia
- 6.6.2.1. Saudi Arabia Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. UAE
- 6.6.3.1. UAE Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. Kuwait
- 6.6.4.1. Kuwait Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. South Africa
- 6.6.5.1. South Africa Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis by Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Heat Map Analysis
- 7.4. Company Profiles
- 7.4.1. GE HealthCare
- 7.4.1.1. Participant's Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Siemens Healthineers AG
- 7.4.2.1. Participant's Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Medtronic
- 7.4.3.1. Participant's Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Aramark
- 7.4.4.1. Participant's Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Koninklijke Philips N.V.
- 7.4.5.1. Participant's Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. B. Braun SE
- 7.4.6.1. Participant's Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. AlphaSource Group
- 7.4.7.1. Participant's Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Althea Group
- 7.4.8.1. Participant's Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.1. GE HealthCare
